# Tandem Diabetes Care (TNDM) — Analyst Forecast

TNDM · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/tndm/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 12 | 11 | 0 | 23 |

## Price target

| Low | Average | High | Analysts |
| --- | --- | --- | --- |
| $18.00 | $22.00 | $28.00 | 5 |

Last price $16.52 (as of Oct 16, 2026).

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Oct 7, 2026 | Barclays | Initiated Coverage | Equal-Weight | $18.00 |
| Sep 30, 2026 | Citigroup | Maintained | Neutral | $20.00 |
| Sep 24, 2026 | Truist Securities | Maintained | Buy | $28.00 |
| Aug 21, 2026 | William Blair | Initiated Coverage | Outperform | — |
| Aug 7, 2026 | RBC Capital | Maintained | Outperform | $26.00 |
| Aug 7, 2026 | Citigroup | Maintained | Neutral | $21.00 |
| Jul 28, 2026 | UBS | Initiated Coverage | Neutral | $18.00 |
| Jul 15, 2026 | Mizuho | Maintained | Neutral | $20.00 |
| Jun 23, 2026 | Deutsche Bank | Initiated Coverage | Buy → Hold | $15.50 |
| Jun 1, 2026 | Wells Fargo | Upgraded | Equal-Weight → Overweight | $27.00 |
| May 28, 2026 | Citigroup | Maintained | Neutral | $17.00 |
| May 18, 2026 | B of A Securities | Maintained | Neutral | $25.00 |
| May 12, 2026 | Benchmark | Initiated Coverage | Hold | — |
| May 11, 2026 | Barclays | Maintained | Overweight | $55.00 |
| May 11, 2026 | Truist Securities | Maintained | Buy | $31.00 |
| Apr 20, 2026 | TD Cowen | Maintained | Buy | $28.00 |
| Apr 9, 2026 | Goldman Sachs | Maintained | Neutral | $25.00 |
| Mar 19, 2026 | Truist Securities | Upgraded | Hold → Buy | $35.00 |
| Mar 17, 2026 | Piper Sandler | Upgraded | Neutral → Overweight | $33.00 |
| Mar 2, 2026 | Morgan Stanley | Maintained | Equal-Weight | $25.00 |

## Frequently Asked Questions

### What is the price target for TNDM stock?

The average 12-month analyst price target for Tandem Diabetes Care (TNDM) is $22.00, with a high estimate of $28.00 and a low of $18.00, across 5 analysts.

### Is TNDM a buy, sell, or hold?

Analysts covering Tandem Diabetes Care currently average a Buy rating: 12 buy, 11 hold and 0 sell, from 23 analysts. Ratings reflect analyst opinion, not investment advice.

### What upside do analysts see for TNDM?

The average price target of $22.00 implies 33.17% upside from the last price of $16.52.

### What is the latest analyst rating on TNDM?

On Oct 7, 2026, Barclays initiated coverage of Tandem Diabetes Care at Equal-Weight with a price target of $18.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).